Complement C1 inhibitor protein - Takeda Inc
At a glance
- Drug Originator Sanquin Blood Supply Foundation
- Drug Licenced by Takeda
- Drug Class Anti-ischaemics; Antianaemics; Complement C1 inactivator proteins; Eye disorder therapies; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Complement C1 inhibitors
- USA Patent Applicants TAKEDA PHARMACEUTICALS AMERICA, INC.
- USA Patents 5
- BLAs 1
- International Patents 6
Disclaimer